| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jan―26 |
Identification of HLA Variants Associated with Symptomatic and Asymptomatic COVID-19 Using a Machine Learning Approach |
Atul Rawal, Zuben Sauna |
| 2 |
[GO] |
2025―Mrz―11 |
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants |
Yun-Jong Park, Wojciech Jankowski, Nicholas C. Hurst, Jeremy W. Fry, Nikolai F. Schwabe, Linda C. C. Tan, Zuben E. Sauna |
| 3 |
[GO] |
2024―Aug―13 |
The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2 |
Kanwal Khalid, Hui Xuan Lim, Jung Shan Hwang, Chit Laa Poh |
| 4 |
[GO] |
2024―Mrz―05 |
A Short Update on the Use of Monoclonal Antibodies in COVID-19 |
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, Antonio Salzano, Andrea Zovi |
| 5 |
[GO] |
2023―Dez―19 |
Quality of New Domestic Hand Sanitizer Drug Product Manufacturers During COVID-19 |
Michelle Stafford, Rachel Linck Dunn, Nirzari Gupta, Raghavi Kakarla, Douglas Kirkpatrick, Daniel Magparangalan, et al. (+10) Diem Ngo, Connie Gryniewicz-Ruzicka, Anjanette Smith, Matthew Stark, Wei Ye, Huzeyfe Yilmaz, Jeffrey Woodruff, Mary Manibusan, Neil Stiber, Alex Viehmann |
| 6 |
[GO] |
2022―Sep―27 |
Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines |
Matthew E. Popkin, Markus Goese, Diane Wilkinson, Stuart Finnie, Talia Flanagan, Cristiana Campa, et al. (+6) Alexandra Clinch, Andrew Teasdale, Andrew Lennard, Graham Cook, Ganapathy Mohan, Matthew D. Osborne |
| 7 |
[GO] |
2022―Sep―02 |
Usage of Compartmental Models in Predicting COVID-19 Outbreaks |
Peijue Zhang, Kairui Feng, Yuqing Gong, Jieon Lee, Sara Lomonaco, Liang Zhao |
| 8 |
[GO] |
2022―Feb―07 |
Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions |
Aditya R. Kolli, Tanja Zivkovic Semren, David Bovard, Shoaib Majeed, Marco van der Toorn, Sophie Scheuner, et al. (+9) Philippe A. Guy, Arkadiusz Kuczaj, Anatoly Mazurov, Stefan Frentzel, Florian Calvino-Martin, Nikolai V. Ivanov, John O’Mullane, Manuel C. Peitsch, Julia Hoeng |
| 9 |
[GO] |
2021―Jan―05 |
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19 |
Joydeb Majumder, Tamara Minko |
| 10 |
[GO] |
2020―Okt―06 |
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies? |
Ronald R. Bowsher, Viswanath Devanarayan |
| 11 |
[GO] |
2020―Sep―17 |
Pulmonary administration of remdesivir in the treatment of COVID-19 |
Henrik Berg Rasmussen, Peter Riis Hansen, Olivier Taboureau, Ragnar Thomsen, Gesche Jürgens |
| 12 |
[GO] |
2020―Aug―02 |
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
Duxin Sun |
| 13 |
[GO] |
2020―Jun―12 |
Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy |
JM. Scherrmann |
| 14 |
[GO] |
2020―Mai―26 |
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit |
Duxin Sun |
|
